Sabine Schmatloch Selected Research

Sabine Schmatloch Research Topics

20	Breast Neoplasms (Breast Cancer) 02/2024 - 06/2013
6	Neoplasms (Cancer) 01/2023 - 11/2016
3	Triple Negative Breast Neoplasms 01/2023 - 01/2019
3	Pathologic Complete Response 01/2023 - 01/2019
2	Neoplasm Metastasis (Metastasis) 12/2020 - 12/2020
1	Amenorrhea 01/2021

6	Hormones (Hormone)IBA 01/2023 - 11/2016
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2017
3	130-nm albumin-bound paclitaxelIBA 01/2023 - 01/2017
2	Letrozole (Femara)FDA LinkGeneric 02/2024 - 02/2024
2	Epirubicin (Ellence)FDA LinkGeneric 01/2023 - 01/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2023
2	Trastuzumab (Herceptin)FDA Link 12/2022 - 01/2021
1	Aromatase InhibitorsIBA 02/2024
1	Ibandronic Acid (Boniva)FDA Link 11/2023
1	Capecitabine (Xeloda)FDA Link 11/2023
1	IceIBA 11/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Caveolin 1IBA 01/2023
1	CaveolinsIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 10/2021
1	Proteins (Proteins, Gene)FDA Link 08/2021
1	Estrogen ReceptorsIBA 08/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	erucylphosphocholineIBA 01/2019
1	SolventsIBA 01/2019
1	ParaffinIBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	AlbuminsIBA 01/2019
1	LigandsIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	human ERBB2 proteinIBA 01/2019

7	Drug Therapy (Chemotherapy) 11/2023 - 11/2016
7	Neoadjuvant Therapy 01/2023 - 06/2013
5	Therapeutics 02/2024 - 01/2019
1	Subcutaneous Injections 12/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Immunotherapy 01/2019
1	Adjuvant Chemotherapy 11/2016